Middle East Respiratory Syndrome (MERS) is a viral respiratory illness caused by the MERS coronavirus (MERS-CoV). It was first identified in humans in 2012 in Saudi Arabia and has since been reported in other countries in the Middle East, Europe, Asia, and the United States. MERS-CoV is a zoonotic virus, meaning it is transmitted from animals to humans. Dromedary camels are considered the primary reservoir of MERS-CoV, and human-to-human transmission can occur, particularly in healthcare settings.
Key Features
-
Symptoms: MERS typically presents with fever, cough, and shortness of breath. Some patients may also experience gastrointestinal symptoms such as diarrhea. Severe cases can progress to pneumonia, acute respiratory distress syndrome (ARDS), and organ failure.
-
Transmission: MERS-CoV primarily spreads through close contact with infected camels or exposure to respiratory secretions from infected individuals. Human-to-human transmission usually occurs through respiratory droplets generated by coughing or sneezing, particularly in healthcare settings.
-
Incubation Period: The incubation period for MERS-CoV is typically around 2 to 14 days, although longer incubation periods have been reported.
-
Severity: MERS can range from mild illness to severe respiratory disease, with a case fatality rate estimated to be around 30%, though this can vary depending on factors such as age and underlying health conditions.
Risk Factors
Certain factors may increase the risk of MERS infection or severe illness:
- Close Contact: Close contact with camels, particularly in areas where MERS-CoV is endemic, increases the risk of infection.
- Healthcare Settings: Healthcare workers caring for MERS patients or working in facilities with inadequate infection control measures are at higher risk of exposure.
- Underlying Health Conditions: Individuals with underlying medical conditions such as diabetes, chronic lung disease, or weakened immune systems may be at higher risk of severe illness if infected with MERS-CoV.
- Travel: Travel to or residence in areas where MERS-CoV is endemic increases the risk of exposure.
Prevention and Control
Preventing MERS-CoV infection involves several measures:
- Hygiene Practices: Practicing good hand hygiene, including regular handwashing with soap and water or using alcohol-based hand sanitizers.
- Avoiding Contact with Camels: Minimizing contact with camels, particularly in areas where MERS-CoV is known to circulate.
- Respiratory Hygiene: Covering the mouth and nose with a tissue or elbow when coughing or sneezing, and disposing of tissues properly.
- Infection Control Measures: Implementing appropriate infection control measures in healthcare settings, including isolating suspected or confirmed MERS cases and using personal protective equipment (PPE).
- Travel Precautions: Travelers to regions where MERS-CoV is circulating should avoid close contact with camels and practice good hygiene.
Diagnosis and Treatment
Diagnosing MERS-CoV infection involves laboratory testing of respiratory specimens, such as nasal swabs or sputum samples, using molecular methods such as polymerase chain reaction (PCR) assays.
There is no specific antiviral treatment for MERS-CoV infection. Supportive care, including oxygen therapy, mechanical ventilation, and treatment of complications, is provided to manage symptoms and improve outcomes. Experimental treatments, including antiviral medications and immunotherapies, may be considered in some cases.
Global Response
The World Health Organization (WHO) collaborates with countries and partners to monitor and respond to MERS outbreaks. Surveillance systems track cases and investigate clusters of illness, and guidance is provided on infection prevention and control measures. Research efforts focus on understanding the epidemiology and transmission dynamics of MERS-CoV and developing vaccines and therapeutics.
Conclusion
MERS is a viral respiratory illness caused by MERS-CoV, primarily transmitted from camels to humans. While MERS outbreaks have occurred sporadically since its identification, the overall risk of infection remains low for the general public, but healthcare workers and travelers to affected regions should take precautions to minimize the risk of exposure. Ongoing surveillance, research, and collaboration are essential for effective prevention and control of MERS-CoV.